Lördag 12 Juli | 15:43:22 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2025-08-22 12:20 Kvartalsrapport 2025-Q2
2025-07-03 - Extra Bolagsstämma 2025
2025-05-30 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2025-03-18 - Bokslutskommuniké 2024
2025-01-14 - Split OBSRV 15:1
2024-08-26 - Kvartalsrapport 2024-Q2
2024-05-27 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2024-05-24 - Årsstämma
2024-03-13 - Bokslutskommuniké 2023
2023-11-22 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2023-05-26 - Årsstämma
2023-02-17 - Bokslutskommuniké 2022
2022-11-03 - 15-10 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2022-06-03 - Årsstämma
2022-03-29 - Bokslutskommuniké 2021
2022-02-04 - Extra Bolagsstämma 2022
2021-11-03 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-25 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2021-05-21 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-02-23 - Bokslutskommuniké 2020
2020-11-03 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2020-06-30 - Årsstämma
2020-06-16 - Extra Bolagsstämma 2020
2020-05-12 - Kvartalsrapport 2020-Q1
2020-02-25 - Bokslutskommuniké 2019

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriMedicinteknik
Observe Medical är ett norskt bolag verksamt inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo, Norge.
2025-07-11 15:00:03
Oslo, July 11, 2025 - Observe Medical ("the Company" or "Observe Medical") is
pleased to announce that it has received first orders for UnoMeterT SafetiT Plus
from distributors covering Argentina and the seven Central American countries.
This comes in addition to a previous order already received from Chile.

These markets together represent approximately 75% of the Company's historic
sales in the region. With a combined population exceeding 600 million, Central
and South America offer a significant commercial opportunity, with an estimated
market potential of NOK 90-100 million in annual recurring revenue for the
UnoMeterT portfolio.

Jørgen Mann, CEO of Observe Medical, commented:

"Central and South America represent important growth markets for Observe
Medical, both geographically and financially. We are pleased to see renewed
momentum in some of the region's most promising countries, and the reactivation
of these markets is a strong endorsement of the UnoMeterT product line. With
local representation now in place, we expect to expand further into other
attractive countries across the region. So far in 2025, we have received orders
for UnoMeterT products from over 40 countries, and we remain focused on
continuing this positive global expansion"

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available atwww.observemedical.com.